1
CRICOS 00026A CRICOS 00026A Nuclear Magnetic Resonance (NMR) with Automated Sampling A SampleJet auto sampler is mounted on our 600 MHz NMR instrument This allows us to automate data collection for up to 480 samples The auto sampler has individual refrigerated racks for optimal temperature control of samples NMR is routinely used to run FBDD screening and validation experiments using both protein-detect and ligand-detect methods for protein: fragment interactions as part of the FBDD workflow The facility also has experience measuring protein: protein, protein: nucleic acid and protein: small molecule interactions using NMR, as well as using NMR to determine protein and protein: small molecule structures In addition to FBDD work, the facility has collected and analyzed metabolomics data sets for a variety of sample types, including human and animal serum, plasma, urine and faeces, along with a variety of different tissue extracts. Sydney Analytical Fragment Based Drug Discovery Equipment and Expertise Surface Plasmon Resonance (SPR) SPR is a technique that allows for the measurement of a variety of biomolecular interactions In SPR the target of interest is immobilised on the surface of a chip, and possible interaction partners are flowed across the surface, and interactions measured We have successfully used this technique within the facility to measure protein: protein, protein: peptide and protein: small molecule interactions for a wide variety of targets, and using several different immobilization strategies. We plan to develop SPR capacity in the facility with the addition of a new SPR system with integrated robotics to enhance our capacity for high throughput sampling under automation For more information Research Portfolio| Sydney Analytical – Drug Discovery T +61 2 9036 5179 Staff Scientist T +61 2 9351 3746 | E [email protected]

Sydney Analytical Fragment Based Drug Discovery › content › dam › corporate › ... · Fragment Based Drug Discovery Equipment and Expertise Surface Plasmon Resonance (SPR)

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Sydney Analytical Fragment Based Drug Discovery › content › dam › corporate › ... · Fragment Based Drug Discovery Equipment and Expertise Surface Plasmon Resonance (SPR)

CRICOS 00026ACRICOS 00026A

Nuclear Magnetic Resonance (NMR)with Automated Sampling• A SampleJet auto sampler is mounted on our 600

MHz NMR instrument• This allows us to automate data collection for up

to 480 samples• The auto sampler has individual refrigerated racks

for optimal temperature control of samples

• NMR is routinely used to run FBDD screening andvalidation experiments using both protein-detectand ligand-detect methods for protein: fragmentinteractions as part of the FBDD workflow

• The facility also has experience measuring protein:protein, protein: nucleic acid and protein: smallmolecule interactions using NMR, as well as usingNMR to determine protein and protein: smallmolecule structures

• In addition to FBDD work, the facility has collectedand analyzed metabolomics data sets for avariety of sample types, including human andanimal serum, plasma, urine and faeces, alongwith a variety of different tissue extracts.

Sydney AnalyticalFragment Based Drug Discovery

Equipment and Expertise

Surface Plasmon Resonance (SPR)• SPR is a technique that allows for the

measurement of a variety of biomolecularinteractions

• In SPR the target of interest is immobilised on thesurface of a chip, and possible interactionpartners are flowed across the surface, andinteractions measured

• We have successfully used this technique withinthe facility to measure protein: protein, protein:peptide and protein: small molecule interactionsfor a wide variety of targets, and using severaldifferent immobilization strategies.

• We plan to develop SPR capacity in the facilitywith the addition of a new SPR system withintegrated robotics to enhance our capacity forhigh throughput sampling under automation

For more informationResearch Portfolio| Sydney Analytical – Drug DiscoveryT +61 2 9036 5179 Staff ScientistT +61 2 9351 3746 | E [email protected]